Hydrochloric Acid → 1-(piperidin-3-yl)-1H-imidazo[4,5-c]pyridin-6-amine hydrochloride
Reaction equation
C1(C(=[N:14][C:15]2[N:20]=[CH:19][C:18]3[N:21]=[CH:22][N:23]([CH:24]4[CH2:29][CH2:28][CH2:27][N:26](C(OC(C)(C)C)=O)[CH2:25]4)[C:17]=3[CH:16]=2)C2C=CC=CC=2)C=CC=CC=1.[ClH:37]>C1COCC1>[ClH:37].[NH:26]1[CH2:27][CH2:28][CH2:29][CH:24]([N:23]2[C:17]3[CH:16]=[C:15]([NH2:14])[N:20]=[CH:19][C:18]=3[N:21]=[CH:22]2)[CH2:25]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of tert-butyl 3-(6-((diphenylmethylene)amino)-1H-imidazo[4,5-c]pyridin-1-yl)piperidine-1-carboxylate (400 mg, 0.83 mmol, 1.0 eq) in THF (4 mL) was added HCl (4 N solution in 1,4 dioxane, 4 mL). The mixture was stirred at rt for 3 h and concentrated in vacuo to afford a residue which was washed with EtOAc (10 mL×3) to give crude title compound (180 mg, 95%) as brown solid. 1H NMR (400 MHz, DMSO-d6) δ: 9.82 (s, 1H), 8.73-8.65 (m, 1H), 7.74-7.70 (m, 1H), 7.58-7.56 (m, 1H), 4.04-4.02 (m, 1H), 3.67-3.66 (m, 0.5H), 3.48-3.32 (m, 2H), 2.95-2.79 (m, 1.5H), 2.18 (s, 1H), 1.99-1.96 (m, 3H), 1.75-1.73 (m, 1H). ESI-MS (M+H+): 218.0.
Workup
- concentrationconcentrated in vacuo
- customto afford a residue which
- washwas washed with EtOAc (10 mL×3)
Sources & evidence
- ORD record
- ord-29ecdd7c2200425c989ba4c69a069d0a
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09273028B2
Reaction notes
Loading…